Pharmasoft

This study tested a drug called Mexidol in 102 adults with moderate to advanced open-angle glaucoma. The goal was to find the best dose to protect vision. Participants received either Mexidol or a placebo, and their visual field was measured over several months.

This study tested a drug called Mexidol, given first as an injection then as a pill, in 318 adults aged 40 to 90 with chronic cerebral ischemia (reduced blood flow to the brain). The goal was to see if it safely improves thinking and memory. Participants received either Mexidol o…

This study tested a medicine called Mexidol in 80 adults with advanced primary open-angle glaucoma. The goal was to see if it can protect the eye's nerve cells and help control the disease. Researchers measured changes in cell energy and vision over time.

This study tested whether adding Mexidol to standard stroke care helps patients recover better after an ischemic stroke. 304 adults with a first stroke were treated within 48 hours and followed for about 10 weeks. Researchers measured disability, neurological symptoms, and mobili…